Literature DB >> 27334896

Rare Case of Hepatic Gaucheroma in a Child on Enzyme Replacement Therapy.

Sophy Korula1, Penny Owens2, Amanda Charlton2, Kaustuv Bhattacharya2.   

Abstract

BACKGROUND: We present a 6 year old boy with type I Gaucher treated from 16 months with ERT, developing focal Gaucheroma in the liver at 3.5 years. CASE: The subject presented at 13 months of age with anaemia, thrombocytopenia and hepatosplenomegaly. Gaucher disease was confirmed by leucocyte enzyme assay. A homozygous change: c.1193G>A (p.Arg398Gln) in the GBA gene was identified. He had normal neurology with normal saccades. Imiglucerase was administered at 60 IU/kg/fortnight from 15 months as per Australian regulations with good clinical response. At 3.5 years hepatic ultrasound demonstrated a nodular cystic lesion measuring 7 × 5.3 × 5.1 cm in the right lobe of liver, confirmed on MRI. Biopsy demonstrated acellular hyaline necrosis, portal-portal bridging fibrosis and nodules of Gaucher cells. Cystic fluid comprised necrotic debris and Gaucher cells. Further evaluation over 18 months including repeat MRI, biopsy, alpha-fetoprotein monitoring and whole-body FDG-Pet scan demonstrate no malignancy.
CONCLUSION: GD is the most common lysosomal storage disorder. The aetiology, natural history and optimal management strategy of rare Gaucheroma in paediatric cases has not been defined particularly in regards to malignancy risk.

Entities:  

Year:  2016        PMID: 27334896      PMCID: PMC5362560          DOI: 10.1007/8904_2016_562

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  15 in total

1.  The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease.

Authors:  J Charrow; H C Andersson; P Kaplan; E H Kolodny; P Mistry; G Pastores; B E Rosenbloom; C R Scott; R S Wappner; N J Weinreb; A Zimran
Journal:  Arch Intern Med       Date:  2000-10-09

Review 2.  Enzyme replacement therapy and monitoring for children with type 1 Gaucher disease: consensus recommendations.

Authors:  Joel Charrow; Hans C Andersson; Paige Kaplan; Edwin H Kolodny; Pramod Mistry; Gregory Pastores; Ainu Prakash-Cheng; Barry E Rosenbloom; C Ronald Scott; Rebecca S Wappner; Neal J Weinreb
Journal:  J Pediatr       Date:  2004-01       Impact factor: 4.406

3.  METABOLISM OF GLUCOCEREBROSIDES. II. EVIDENCE OF AN ENZYMATIC DEFICIENCY IN GAUCHER'S DISEASE.

Authors:  R O BRADY; J N KANFER; D SHAPIRO
Journal:  Biochem Biophys Res Commun       Date:  1965-01-18       Impact factor: 3.575

4.  The clinical and demographic characteristics of nonneuronopathic Gaucher disease in 887 children at diagnosis.

Authors:  Paige Kaplan; Hans C Andersson; Katherine A Kacena; John D Yee
Journal:  Arch Pediatr Adolesc Med       Date:  2006-06

Review 5.  Hepatocellular carcinoma in type 1 Gaucher disease: a case report with review of the literature.

Authors:  Ruliang Xu; Pramod Mistry; Gregg McKenna; Sukru Emre; Thomas Schiano; Moueen Bu-Ghanim; Gabriel Levi; Maria Isabel Fiel
Journal:  Semin Liver Dis       Date:  2005       Impact factor: 6.115

6.  Peripheral neuropathy in adult type 1 Gaucher disease: a 2-year prospective observational study.

Authors:  Marieke Biegstraaten; Eugen Mengel; Laszlo Maródi; Milan Petakov; Claus Niederau; Pilar Giraldo; Derralyn Hughes; Mirando Mrsic; Atul Mehta; Carla E M Hollak; Ivo N van Schaik
Journal:  Brain       Date:  2010-08-07       Impact factor: 13.501

7.  Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher Registry.

Authors:  Neal J Weinreb; Joel Charrow; Hans C Andersson; Paige Kaplan; Edwin H Kolodny; Pramod Mistry; Gregory Pastores; Barry E Rosenbloom; C Ronald Scott; Rebecca S Wappner; Ari Zimran
Journal:  Am J Med       Date:  2002-08-01       Impact factor: 4.965

8.  Splenic nodules in paediatric Gaucher disease treated by enzyme replacement therapy.

Authors:  Samantha Chippington; Kieran McHugh; Ashok Vellodi
Journal:  Pediatr Radiol       Date:  2008-04-01

Review 9.  Gaucher disease and malignancy: a model for cancer pathogenesis in an inborn error of metabolism.

Authors:  Pramod K Mistry; Tamar Taddei; Stephan vom Dahl; Barry E Rosenbloom
Journal:  Crit Rev Oncog       Date:  2013

10.  Long-term effectiveness of enzyme replacement therapy in children with Gaucher disease: results from the NCS-LSD cohort study.

Authors:  L J Anderson; W Henley; K M Wyatt; V Nikolaou; S Waldek; D A Hughes; G M Pastores; S Logan
Journal:  J Inherit Metab Dis       Date:  2014-03-18       Impact factor: 4.982

View more
  3 in total

1.  Elevated Alpha-Fetoprotein in Infantile-Onset Niemann-Pick Type C Disease with Liver Involvement.

Authors:  Dror Kraus; Huda Abdelrahim; Orith Waisbourd-Zinman; Elena Domin; Avraham Zeharia; Orna Staretz-Chacham
Journal:  Children (Basel)       Date:  2022-04-12

2.  Very rare condition of multiple Gaucheroma: A case report and review of the literature.

Authors:  Szu-Yin Tseng; Dau-Ming Niu; Tzu-Hung Chu; Yi-Chen Yeh; Man-Hsu Huang; Tsui-Feng Yang; Hsuan-Chieh Liao; Chuan-Chi Chiang; Hui-Chen Ho; Wen-Jue Soong; Chia-Feng Yang
Journal:  Mol Genet Metab Rep       Date:  2019-05-09

3.  Very rare condition of multiple Gaucheroma: A case report and review of the literature.

Authors:  Szu-Yin Tseng; Dau-Ming Niu; Tzu-Hung Chu; Yi-Chen Yeh; Man-Hsu Huang; Tsui-Feng Yang; Hsuan-Chieh Liao; Chuan-Chi Chiang; Hui-Chen Ho; Wen-Jue Soong; Chia-Feng Yang
Journal:  Mol Genet Metab Rep       Date:  2019-07-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.